Conrad, Mark F <br/><br/>
Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.  [electronic resource] 

 -  The Journal of surgical research  Oct 2006 
 - 233-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0022-4804 
<br/><br/><label>Standard No.: </label>10.1016/j.jss.2006.04.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Enzyme-Linked Immunosorbent Assay<br/>Hindlimb--blood supply<br/>Interleukin-1beta--metabolism<br/>Interleukin-6--metabolism<br/>Laser-Doppler Flowmetry<br/>Mice<br/>Muscle, Skeletal--blood supply<br/>Peroxidase--metabolism<br/>Phenanthrenes--pharmacology<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Reperfusion Injury--drug therapy